{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:30:53Z","timestamp":1762018253599},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.medcli.2019.10.015","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T21:12:18Z","timestamp":1582405938000},"page":"148-149","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neumonitis eosinof\u00edlica por daptomicina"],"prefix":"10.1016","volume":"156","author":[{"given":"Raquel","family":"Fern\u00e1ndez-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"D\u00edaz L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Lorenzo Vizcaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amara","family":"Gonz\u00e1lez Noya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2019.10.015_bib0030","unstructured":"FDA Drug And Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin) [consultado en Sept 2019] Disponible en: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin"},{"key":"10.1016\/j.medcli.2019.10.015_bib0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJM198908313210903","article-title":"Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure","volume":"321","author":"Allen","year":"1989","journal-title":"N Eng J Med"},{"key":"10.1016\/j.medcli.2019.10.015_bib0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1183\/09031936.00221811","article-title":"Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia","volume":"41","author":"Rhee","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.medcli.2019.10.015_bib0045","first-page":"4","article-title":"Drug-induced eosinophilic pneumonia","volume":"97","author":"Carmi","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.medcli.2019.10.015_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13756-016-0158-8","article-title":"Daptomycin-induced eosinophilic pneumonia -a systematic review","volume":"5","author":"Uppal","year":"2016","journal-title":"Antimicrob Resist Infect Control"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320300397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320300397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T20:24:35Z","timestamp":1611433475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775320300397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0025775320300397"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2019.10.015","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neumonitis eosinof\u00edlica por daptomicina","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2019.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}